Hmmm. I've read your comment twice now, and it seems like you have glossed over the entire observation and assertion that Rushworth (and Gupta, and Henneghan, and Kulldorff, and other reputable experts) are making with what amounts to a side note in your comment:
> Also the 4 other coronaviruses circulating thing is silly, obviously the long term effects of the common cold viruses are not going to be comparable if the short term effects are clearly not comparable, it is reductionism of the worst kind.
What you are saying is "obvious" is not at all obvious, and is not the assessment of the experts who have looked at the data and weighed in.
In terms of obviousness: why do you think that the long term effects are unlikely to be comparable (if not strikingly similar), since the long term (adverse) effects of each of these four (and also several of the influenza A) viruses seem to be clinically identical, despite each having distinguishable acute characteristics?
> This is just getting caught up in silly semantics, people are experiencing longer term health effects, they are calling it "long covid" for lack of a better name not because it is an affirmative diagnosis.
I agree that the terminology becomes tricky. But I think the question is better stated as: is "long COVID19" any different from other "long covid" (ie, the rare but well known post-viral syndrome that is observed with all coronaviruses).
> Even if truly long term effects only develop in 1 in 500 COVID-19 cases.. that's a lot of people who are going to be sick for a really long time! It would be 400 Americans a day right now.
...but a relatively small cohort in the bigger picture of post-viral syndrome, if indeed it occurs with approximately equal frequency with the other coronaviruses (and some influenza A viruses).
I think we need to be careful about measuring potential adverse outcomes against one another, and try our best to use numbers that reflect the likely lived experience of people (to wit, nearly everyone contracts the "garden variety" coronaviruses a few times in their life).
If the current slate of vaccines don't prevent this effect, then I'm having trouble putting any math together that suggests that it will generally reduce population-level instances of "long covid" (again, defined broadly as long effects from any covid, not just COVID19).